Academic literature on the topic 'HCT-116 cells'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'HCT-116 cells.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "HCT-116 cells"
Luminturahardjo, Winarko, Djoko Wahono Soeatmadji, Karyono Mintaroem, Pudji Rahajoe, and Ferry Sandra. "N-Cadherin as An Important Marker in Colorectal Cancer: An investigation of b-Catenin and Cadherin Expressions of SW-480 and HCT-116 Cell Lines." Indonesian Biomedical Journal 13, no. 3 (September 9, 2021): 289–94. http://dx.doi.org/10.18585/inabj.v13i3.1562.
Full textHsieh, Shu-Ling, Shuchen Hsieh, Yu-Hao Kuo, Jyh-Jye Wang, Jinn-Chyi Wang, and Chih-Chung Wu. "Effects of Panax notoginseng on the Metastasis of Human Colorectal Cancer Cells." American Journal of Chinese Medicine 44, no. 04 (January 2016): 851–70. http://dx.doi.org/10.1142/s0192415x16500476.
Full textLeong, Lek Mun, Kok Meng Chan, Asmah Hamid, Jalifah Latip, and Nor Fadilah Rajab. "Herbal Formulation C168 Attenuates Proliferation and Induces Apoptosis in HCT 116 Human Colorectal Carcinoma Cells: Role of Oxidative Stress and DNA Damage." Evidence-Based Complementary and Alternative Medicine 2016 (2016): 1–12. http://dx.doi.org/10.1155/2016/2091085.
Full textWu, Peng, Ting Yu, Jun Wu, and Junfeng Chen. "Licochalcone a Induces ROS-Mediated Apoptosis through TrxR1 Inactivation in Colorectal Cancer Cells." BioMed Research International 2020 (May 28, 2020): 1–11. http://dx.doi.org/10.1155/2020/5875074.
Full textHuang, Ya-Li, Fang Wei, Ke Zhao, Yong Zhang, Dong Wang, and Xin-Hua Li. "Isoliquiritigenin inhibits colorectal cancer cells HCT-116 growth by suppressing the PI3K/AKT pathway." Open Life Sciences 12, no. 1 (October 23, 2017): 300–307. http://dx.doi.org/10.1515/biol-2017-0035.
Full textMasese Osoro Brian and Selvi S. "Cytotoxic effects of Ceiba pentandra L. mediated silver nanoparticles on HCT-116 colon cancer cell lines through ROS generation and cell membrane damage." International Journal of Research in Pharmaceutical Sciences 10, no. 4 (October 16, 2019): 3236–43. http://dx.doi.org/10.26452/ijrps.v10i4.1627.
Full textBian, Zhongbo, Xiaodie Sun, Lulin Liu, Yong Qin, Qiuyu Zhang, Huahuan Liu, Lianzhi Mao, and Suxia Sun. "Sodium Butyrate Induces CRC Cell Ferroptosis via the CD44/SLC7A11 Pathway and Exhibits a Synergistic Therapeutic Effect with Erastin." Cancers 15, no. 2 (January 9, 2023): 423. http://dx.doi.org/10.3390/cancers15020423.
Full textKırımtay, Koray, Ece Selçuk, Dolunay Kelle, Batu Erman, and Arzu Karabay. "p53 regulates katanin-p60 promoter in HCT 116 cells." Gene 727 (February 2020): 144241. http://dx.doi.org/10.1016/j.gene.2019.144241.
Full textZhang, Haiying, Jianan Sun, Ruoting Ma, and Shengjun Zhao. "Role of Episamarcandin in Promoting the Apoptosis of Human Colon Cancer HCT116 Cells through the PI3K-Akt Signaling Pathway." Evidence-Based Complementary and Alternative Medicine 2021 (November 2, 2021): 1–12. http://dx.doi.org/10.1155/2021/9663738.
Full textApaydin Yildirim Betul. "Anti-cancer, antiproliferative activity of active anionic H2O8 oxygen solution on HCT-116 cancer cell." World Journal of Advanced Research and Reviews 12, no. 2 (November 30, 2021): 179–84. http://dx.doi.org/10.30574/wjarr.2021.12.2.0560.
Full textDissertations / Theses on the topic "HCT-116 cells"
Perwaiz, Sunela. "Effect of 5-Flourouracil On HCT-116 P53+/- Human Colon Cancer Cells." Thesis, Högskolan i Skövde, Institutionen för vård och natur, 2011. http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-6351.
Full textAlotaibi, Moureq. "CELL DEATH AND GROWTH ARREST PATHWAYS MEDIATING THE ACTIONS OF STILBENE 5C IN HCT-116 COLON CANCER CELLS." VCU Scholars Compass, 2012. http://scholarscompass.vcu.edu/etd/2851.
Full textGentile, Michelle Sara. "Analysis of p53 loss using combined metabolite and transcript profiling in HCT-116 colon cancer cells." Thesis, University of Cambridge, 2009. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.611322.
Full textShipley, Lindsey C. BS, Harika MD Balagoni, Janet Lightner, Victoria PhD Palau, and Koyamangalath MD Krishnan. "15 Lox 1 Up-regulation and Cytotoxicity with γ-tocotrienol in HCT-116 Colon Cancer Cells." Digital Commons @ East Tennessee State University, 2018. https://dc.etsu.edu/asrf/2018/schedule/154.
Full textDave, Havya. "Effects Of Vitamin E Isomer, Gamma Tocotrienol (GT3), At Inhibiting Cell Growth And Inducing Apoptosis In Colon Cancer Cell Line HCT-116." Digital Commons @ East Tennessee State University, 2011. https://dc.etsu.edu/honors/128.
Full textJu, Sy-Yeuan, and 朱思遠. "Elucidation of the role of CD44 in colon cancer stem cells derived from HCT-15 and HCT-116 lines and identification of drugs targeting this population." Thesis, 2014. http://ndltd.ncl.edu.tw/handle/98156533506941235113.
Full text國立陽明大學
生物藥學研究所
102
Cancer stem cells (CSCs) are known to play critical roles in tumor initiation and progression. Accumulating evidence also shows that CSCs are responsible for tumor relapse after chemotherapy. The purpose of this study was to isolate CSCs from established human colorectal carcinoma (CRC) cell lines, characterize them thoroughly and dissect the mechanism of their stemness. Additionally, identifying novel agents capable of specifically targeting colorectal cancer stem cells (CRSCs) that may improve CRC treatment is the other goal of this work. To reach the first aim, freshly isolated CD44+ and CD44- cells from the HCT-15 human CRC line were subjected to various analyses. Interestingly, CD44+ cells exhibited higher soft agar colony-forming ability and in vivo tumorigenicity than the CD44- ones. In addition, a significant upregulation of the protein level of Snail and a marked downregulation of miR-203, a stemness inhibitor, were found in CD44+ HCT-15 cells which suggested that this EMT activator and microRNA might be crucial for the generation and/or maintenance of CRSCs. Moreover, the levels of several other EMT inducers and miR-203 were found to be positively and negatively correlated with those of CD44, respectively, in both HCT-15 and HCT-116 cells. Interestingly, further analyses revealed that miR-203 levels were repressed by Snail, which was shown to bind directly to specific E-box(es) present in the miR-203 promoter. In agreement, silencing miR-203 expression in wild-type HCT-116 cells also resulted in an increase of their stemness. Finally, I discovered that c-Src kinase activity was required for the downregulation of miR-203 in HCT-15 cells, which was stimulated by the interaction between hyaluronan (HA) and CD44. With respect to the identification of agent(s) capable of selectively targeting CRSCs, I found that Compound X, was the most effective one among the compounds provided kindly by Professor Chi-Yin Huang of our Institute after a quick primary screening. In fact, Compound X could dose-dependently diminish the CRSC populations present in both HCT-15 and HT-29 cells as well as induce apoptosis of the CRSCs-enriched oxaliplatin-resistant HT-29 cells. Additionally, this Compound not only inhibited spheroid- and colony-forming abilities of HCT-15 and HT-29 cells drastically but also suppressed the expression of several well-defined pluripotency factors such as Oct4, Nanog, and Bmi1 as well as EMT inducers Snail and Twist. Moreover, Compound X could act synergistically with oxaliplatin to kill HCT-15 and HT-29 cells, especially their CD44+ populations. Finally, I showed that not only was the percentage of SC population decreased significantly but also the sensitivity to Compound X was notably reduced in both HT-29 and HCT-116 lines by RNAi-mediated silencing of transcriptional factor Y, an oncogenic transcription factor, a SC self-renewal promoter, and a well-defined target of this antibiotic. Taken together, this study shows that CD44 is critical for modulating stemness in CSCs, at least those present in HCT-15 and HCT-116 human CRC lines. More importantly, my results demonstrate that the downregulation of miR-203 mediated by HA/CD44 signaling is the main reason for stemness maintenance in the aforementioned CRSCs. In the meantime, I identify and validate the selective inhibitory effects of Compound X on various CRSCs although this antibiotic has already been shown to be active against a wide variety of types of tumors. Judging by its good synergism with oxaliplatin, Compound X may be used in combination with the clinically available chemotherapeutic drugs to improve CRC treatments.
Szu-Wei, Huang, and 黃思瑋. "Dissecting the mechanisms underlying stemness reduction mediated by miR-203 in HT-29 and HCT-116 human colon cancer cells." Thesis, 2014. http://ndltd.ncl.edu.tw/handle/77287063361485031527.
Full text國立陽明大學
生物藥學研究所
102
Cancer stem cells (CSCs) or tumor-initiating cells (TICs) are defined as a small subpopulation present in tumors responsible for the initiation, metastasis, recurrence and treatment resistance of a wide variety of cancers including colorectal carcinoma (CRC). Our previous study has shown that downregulated expression of miR-203 is crucial for the increased stemness of HCT-15 and HCT-116 human CRC cells triggered by the interaction between cell surface CD44 and its main ligand, hyaluronan (HA). However, the precise role(s) of miR-203 in modulating the stemness of these cells is largely undefined. To assess the contributions of miR-203 in colorectal cancer stem cells (CRSCs), miR-203-overexpressing and -sequestered stable clones derived from both HT-29 and HCT-116 human CRC cells were established, respectively. Supporting our previous observations, overexpression and sequestration of miR-203 resulted in a significant reduction and a marked increase of self-renewal in these cells, respectively. Moreover, overexpression of miR-203 in these cells also drastically reduced their anchorage- independent growth abilities. In addition, surface levels of CD44, a prominent CRSC marker, as well as mRNA and protein levels of several SC markers (i.e., Nanog, Oct-4 and Bmi1) in these cells were also inversely correlated with miR-203 levels. To further delineate the mechanism underlying the stemness-diminishing effects of miR-203, its potential targets were searched by miRWalk. Among those identified, GATA6 and IL-8 were the most interesting ones since their well-known roles in normal intestinal SCs and CRSCs, respectively. Subsequently, reporter assay using a luciferase gene fused with the 3' untranslated region (3'-UTR) of GATA6 mRNA confirmed that GATA6 was indeed a direct target of miR-203. In accordance, GATA6 knockdown in HT-29 and HCT-116 cells inhibited the expression of not only CD44 but also Lgr5, a newly identified GATA6 target which plays a crucial role in potentiating Wnt signaling in various SCs. Moreover, I found that increased Lgr5 expression in miR-203-sequestered clones was due mainly to GATA6 stimulation. In addition, the levels of Dickkopf-related protein 1 (DKK1), a Wnt antagonist known to be repressed by GATA6, were found to be significantly increased in miR-203-overexpressing HT-29 and HCT-116 cells, which might account at least in part for their stemness reduction. Fittingly, protein levels of β-catenin, the main mediator of Wnt signaling were also downregulated in miR-203-overexpressing and GATA6-knockdowned CRC cells. In the meantime, sphere-forming abilities marked decreases of IL-8 levels were detected in miR-203-overexpressing HT-29 cells whose could be partially restored by exogenous IL-8. Taken together, my data demonstrate that miR-203 suppresses the stemness of CRSCs present in HT-29 and HCT-116 lines by downregulating GATA6, resulting in diminished Wnt signaling due likely to a concomitant Lgr5 repression and DKK1 activation. In the meantime, reduced IL-8 production is also partially responsible for the stemness-inhibitory effects of this miR. .
Shih, Ting-Ying, and 史亭瑩. "Sulforaphane induces cell death through the G2/M phase arrest and apoptosis by reactive oxygen species dependent pathway in human colon cancer HCT 116 cells." Thesis, 2014. http://ndltd.ncl.edu.tw/handle/ny966u.
Full text中國醫藥大學
醫學檢驗生物技術學系碩士班
102
Sulforaphane (SFN) is a rather simple organic compound that is found in the largest concentrations in the cruciferous or mustard family of plants, including broccoli, cauliflower, and cabbage. It has been reported to exhibit a wide variety of biological activities including antioxidant, prevent and treat arthritis, protect against respiratory ailments and prevention of heart disease effects. In addition, it has been shown to inhibit the proliferation and to induce the apoptosis of a wide variety of tumor cells including breast, prostate and lung cancers. However, it is still unclear whether SFN effectively induces apoptotic cell death of human colon cancer HCT 116 cells. Herein, HCT 116 cells were treated with different concentrations of SFN for a specific time period and investigated for effects on apoptosis analyses. Our results indicated that HCT 116 cells after exposure to SFN significantly decreased cell viability, induced cell morphological changes, DNA damage, fragment and cause G2/M phase arrest. Western blotting results indicated that SFN inhibit cyclin A and cdk1 expressions and promoted chk-1 and chk-2 levels that were caused G2/M phase arrest. Flow cytometry assay indicated that SFN promoted calcium productions, increased percentage of early apoptotic cells and loss of mitochondrial membrane potential and resulted from cell death pathway such as the Caspase-3, -8, -9 active form and changed protein levels of Bcl-2 family in HCT 116 cells. Western blot analytics proved the increase of pro-apoptotic proteins such as Bax, AIF, Endo G, Cytochrome c, Caspase-3, and the declined the anti-apoptotic proteins, such as Bcl-2, XIAP, Mcl-1. In the future, SFN may be useful for developing new therapeutic regimens for the treatment of human colon cancer.
Li, Tain-Yu, and 李天佑. "Tea extract (EGCG or TF-3-G) inhibits cell cycle progression through JNK signaling in HCT-116 human colorectal cancer cell line." Thesis, 2012. http://ndltd.ncl.edu.tw/handle/85705898222279799620.
Full text中山醫學大學
口腔科學研究所
101
Catechins in cancer-related research have received great attention in recent years. The (-)-epigallocatechin-3-gallate (EGCG) are most abundant compound in extracted that effective inhibits the growth of cancer cells. Theaflavins extracted from completely fermented black tea are also inhibits the growth of cancer cells effectively. In this study, we use human colorectal cancer cell lines that were treated with tea extracts such as EGCG or TF-3-G, and their effects on the HCT116 cells were investigated. EGCG or TF-3-G inhibits the growth of HCT-116 cells through triggering the G2/M arrest in HCT-116. We further examined cellular-signaling protein and found that EGCG or TF3-G increase the activities of JNK and also p53 and p21 expression, but reduces Cyclin A and Cyclin B expression. HCT-116 cells pre-treated with JNK Inhibitor (SP600125) before adding EGCG or TF-3-G were examined and we found that EGCG or TF-3-G is able to reverse G2/M arrest in HCT-116, wherein p53, p21, cyclin A and cyclinB protein levels are not significantly changed comparison to cells without treated EGCG or TF-3-G. We found that EGCG or TF-3-G inhibits HCT-116 cells growth through mechanisms that influence on the activity of JNK signaling pathway, and future change cyclin A and Cyclin B expression levels to induce cell cycle arrest.
Book chapters on the topic "HCT-116 cells"
Skonieczna, Magdalena, Dorota Hudy, Patryk Bil, Malgorzata Adamiec, Marta Stachowska, and Krzysztof Biernacki. "Role of Let-7 Family miRNAs in Migration of Colorectal Cancer HCT 116 and Caco-2 Cells After Stimulation by the Adipokine Vaspin. Time-Lapse Live-Cell Microscopic Observations." In Advances in Intelligent Systems and Computing, 47–61. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-29885-2_5.
Full textPatil, Poounima, and Suresh Killedar. "Colon Available Bioactive Compounds Exhibits Anticancer Effect on In-Vitro Model of Colorectal Cancer." In Biosynthesis [Working Title]. IntechOpen, 2021. http://dx.doi.org/10.5772/intechopen.96632.
Full textConference papers on the topic "HCT-116 cells"
Šeklić, Dragana, Milena Jovanović, Nevena Milivojević, and Marko Živanović. "PLATINUM(IV) COMPLEX AND ITS CORRESPONDING LIGAND SUPPRESS CELL MOTILITY AND PROMOTE EXPRESSION OF FRIZZLED-7 RECEPTOR IN COLORECTAL CANCER CELLS." In 1st INTERNATIONAL Conference on Chemo and BioInformatics. Institute for Information Technologies, University of Kragujevac, 2021. http://dx.doi.org/10.46793/iccbi21.288s.
Full textJovanović, Milena M., Katarina Virijević, Jelena Pavić, Dejan Arsenijević, Katarina Pecić, Nikolina Kastratović, Marko Živanović, and Dragana Šeklić. "Antimigratory Activity of Royal Jelly on HCT-116 Colorectal Cancer Cells." In Foods 2022. Basel Switzerland: MDPI, 2022. http://dx.doi.org/10.3390/foods2022-12951.
Full textDachineni, Rakesh, Goqiang Ai, and Jayarama B. Gunaje. "Abstract 3501: Aspirin modulates oncogene expression in hct 116 colon cancer cells." In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-3501.
Full textSubroto, Priscilla Aya Maheswari, Ade Arsianti, Trivani Putri, and Elvira Lesmana. "Phytochemical analysis and anticancer activity of seaweed Eucheuma Sp. against colon HCT-116 cells." In SECOND INTERNATIONAL CONFERENCE OF MATHEMATICS (SICME2019). Author(s), 2019. http://dx.doi.org/10.1063/1.5096719.
Full textGursoy, Duygu. "Anti-cancer effect of Mirtazapine against MCF-7, HCT-116 and MiaPaCa-2 cancer cells." In 15th International Congress of Histochemistry and Cytochemistry. Istanbul: LookUs Scientific, 2017. http://dx.doi.org/10.5505/2017ichc.pp-121.
Full textGunaje, Jayarama B., Srinivasan Marimuthu, Raghavender S. V. Chivukula, Majid Moridani, Fred K. Hagen, and Lloyd F. Alfonso. "Abstract 1638: Aspirin acetylates multiple cellular proteins in HCT-116 cells: Identification of novel targets." In Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-1638.
Full textAlfonso, Lloyd F., Raghavender Chivukula, Srinivasan Marimuthu, and Jayarama B. Gunaje. "Abstract 5041: Aspirin acetylates and activates p53 in HT-29 and HCT-116 colon cancer cells." In Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-5041.
Full textMilenković, Dejan A., Marko N. Živanović, Milan S. Dekić, Marijana Stanojević Pirković, and Jelena R. Đorović Jovanović. "CYTOTOXIC ACTIVITY AND MOLECULAR DOCKING STUDY OF 4- SUBSTITUTED FLAVYLIUM SALT." In 1st INTERNATIONAL Conference on Chemo and BioInformatics. Institute for Information Technologies, University of Kragujevac,, 2021. http://dx.doi.org/10.46793/iccbi21.466m.
Full textAlotaibi, Moureq R., Matthew J. Beckman, Xu Di, Ray Lee, and David A. Gewirtz. "Abstract 3957: Cell death and growth arrest pathways mediating the actions of stilbene 5C in HCT-116 colon cancer cells." In Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-3957.
Full textAlotaibi, Moureq R. "Abstract 1658: Cell death and growth arrest pathways mediating the actions of stilbene 5c in HCT-116 colon cancer cells and B16F10 melanoma cells." In Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.am2013-1658.
Full text